Sign in

CIK 0000926617

  • Non-accelerated filer
  • Smaller reporting company

Aspira Women's Health Inc.

Sign in to watch
Ticker
AWHL
Exchange
OTC
Industry
In Vitro & In Vivo Diagnostic Substances
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330595156
Phone
+1 512-519-0400
Business address
12117 BEE CAVES ROAD BUILDING THREE, SUITE 100, AUSTIN, TX, 78738
Former names
VERMILLION, INC., CIPHERGEN BIOSYSTEMS INC
  1. 4 Open-market buy VP Sales and Marketing bought 374 shares at $5.28 ($1,975)
  2. 3 Insider Initial Statement of Ownership
  3. 4 Grant or award Director acquired 18,200 shares (grant or award)
  4. 4 Grant or award Director acquired 19,200 shares (grant or award)
  5. 4 Grant or award Director acquired 15,200 shares (grant or award)
  6. 4 Grant or award Director acquired 15,200 shares (grant or award)
  7. 4 Grant or award Director acquired 20,000 shares (grant or award)
  8. 4 Grant or award VP & Chief Financial Officer acquired 24,000 shares (grant or award)
  9. 4 Grant or award Chief Executive Officer acquired 85,000 shares (grant or award)
  10. 4 Grant or award SVP and Chief Science Officer acquired 41,000 shares (grant or award)
  11. 4 Grant or award VP Sales and Marketing acquired 20,000 shares (grant or award)
  12. 4 Grant or award VP of Corporate Strategy acquired 7,000 shares (grant or award)
  13. 4 Open-market sale Chief Executive Officer sold 45,000 shares at $5.92 ($266,400)
  14. 4 Open-market sale Director sold 6,000 shares at an average $5.68 ($34,075)
  15. 4 Grant or award Chief Executive Officer acquired 181,525 shares (grant or award)
  16. 4 Grant or award Director acquired 13,000 shares (grant or award)
  17. 4 Grant or award Director acquired 17,500 shares (grant or award)
  18. 4 Grant or award Director acquired 13,000 shares (grant or award)
  19. 4 Grant or award Director acquired 22,000 shares (grant or award)
  20. 4 Grant or award Director acquired 15,500 shares (grant or award)

Page 21 of 28 · 551 filings